{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:06:11Z","timestamp":1789477571101,"version":"build-2803163510"},"reference-count":116,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.14797\/mdcvj.1900","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:38:03Z","timestamp":1789475883000},"page":"51-67","source":"Crossref","is-referenced-by-count":0,"title":["Hypertrophic Cardiomyopathy is a Disease of Sarcomere Proteins"],"prefix":"10.14797","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-7120","authenticated-orcid":false,"given":"A. J.","family":"Marian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"SUPPL 4","key":"key20260915123757_B1","first-page":"3","article-title":"Idiopathic Hypertrophic Subaortic Stenosis. I. A Description of the Disease Based Upon an Analysis of 64 Patients","volume":"30","year":"1964","journal-title":"Circulation"},{"issue":"10","key":"key20260915123757_B2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMra2413445","article-title":"Hypertrophic Cardiomyopathy","volume":"393","year":"2025","journal-title":"N Engl J Med"},{"issue":"37","key":"key20260915123757_B3","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"key20260915123757_B4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.hlc.2023.10.021","article-title":"Clinical to Population Prevalence of Hypertrophic Cardiomyopathy Phenotype: Insights From the National Echo Database Australia","volume":"33","year":"2024","journal-title":"Heart Lung Circ"},{"issue":"3","key":"key20260915123757_B5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0735-1097(83)80269-1","article-title":"Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study","volume":"2","year":"1983","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20260915123757_B6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy","volume":"78","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"key20260915123757_B7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jamacardio.2021.0689","article-title":"Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population","volume":"6","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"4","key":"key20260915123757_B8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"key20260915123757_B9","doi-asserted-by":"crossref","first-page":"18799","DOI":"10.1038\/s41598-022-20042-9","article-title":"Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China","volume":"12","year":"2022","journal-title":"Sci Rep"},{"issue":"19","key":"key20260915123757_B10","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry","volume":"74","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20260915123757_B11","article-title":"Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta-Analysis","volume":"12","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"key20260915123757_B12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/hrt.11.1.68","article-title":"Familial cardiomegaly","volume":"11","year":"1949","journal-title":"Br Heart J"},{"issue":"1","key":"key20260915123757_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"20","year":"1958","journal-title":"Br Heart J"},{"key":"key20260915123757_B14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(61)90222-4","article-title":"Hereditary cardiovascular dysplasia.A form of familial cardiomyopathy","volume":"31","year":"1961","journal-title":"Am J Med"},{"issue":"5","key":"key20260915123757_B15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation","volume":"62","year":"1990","journal-title":"Cell"},{"issue":"10","key":"key20260915123757_B16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular Genetic Basis of Hypertrophic Cardiomyopathy","volume":"128","year":"2021","journal-title":"Circ Res"},{"issue":"16","key":"key20260915123757_B17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"key20260915123757_B18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng0897-379","article-title":"Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy","volume":"16","year":"1997","journal-title":"Nat Genet"},{"issue":"7571","key":"key20260915123757_B19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project C","year":"2015","journal-title":"Nature"},{"issue":"6822","key":"key20260915123757_B20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"International Human Genome Sequencing C. Initial sequencing and analysis of the human genome","volume":"409","year":"2001","journal-title":"Nature"},{"issue":"9","key":"key20260915123757_B21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"key20260915123757_B22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"key20260915123757_B23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.116.310559","article-title":"A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder","volume":"120","year":"2017","journal-title":"Circ Res"},{"key":"key20260915123757_B24","first-page":"12","article-title":"A combinatorial oligogenic basis for the phenotypic plasticity between late-onset dilated and arrhythmogenic cardiomyopathy in a single family","volume":"1","year":"2021","journal-title":"J Cardiovasc Aging"},{"issue":"2","key":"key20260915123757_B25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","year":"2017","journal-title":"Genet Med"},{"issue":"11","key":"key20260915123757_B26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"key20260915123757_B27","article-title":"Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications","volume":"10","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"20","key":"key20260915123757_B28","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/hmg\/ddm202","article-title":"Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy","volume":"16","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"2","key":"key20260915123757_B29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gene.2015.09.008","article-title":"Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology","volume":"573","year":"2015","journal-title":"Gene"},{"issue":"3","key":"key20260915123757_B30","article-title":"Post-translational modifications of cardiac myosin-binding protein-C: Mechanisms behind fine-tuning the sarcomere","volume":"158","year":"2026","journal-title":"J Gen Physiol"},{"key":"key20260915123757_B31","doi-asserted-by":"crossref","first-page":"109788","DOI":"10.1016\/j.cellsig.2020.109788","article-title":"Post-translational regulation of cardiac myosin binding protein-C: A graphical review","volume":"76","year":"2020","journal-title":"Cell Signal"},{"issue":"3","key":"key20260915123757_B32","article-title":"Reevaluation of the South Asian MYBPC3(Delta25bp) Intronic Deletion in Hypertrophic Cardiomyopathy","volume":"13","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"14","key":"key20260915123757_B33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/CIRCULATIONAHA.114.011207","article-title":"Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation","volume":"130","year":"2014","journal-title":"Circulation"},{"issue":"20","key":"key20260915123757_B34","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0195-668X(03)00466-4","article-title":"The 2373 insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands","volume":"24","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"key20260915123757_B35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","article-title":"Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice","volume":"105","year":"2009","journal-title":"Circ Res"},{"issue":"6","key":"key20260915123757_B36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","article-title":"A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay","volume":"139","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"key20260915123757_B37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"key20260915123757_B38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","year":"2009","journal-title":"Circ Res"},{"issue":"5","key":"key20260915123757_B39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCGEN.120.002929","article-title":"Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy","volume":"13","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"8","key":"key20260915123757_B40","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000245191.34690.66","article-title":"Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C","volume":"99","year":"2006","journal-title":"Circ Res"},{"issue":"24","key":"key20260915123757_B41","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1073\/pnas.1821660116","article-title":"Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin","volume":"116","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"key20260915123757_B42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.112.275602","article-title":"GSK3beta phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communication","volume":"112","year":"2013","journal-title":"Circ Res"},{"key":"key20260915123757_B43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-physiol-042222-022728","article-title":"Regulating Striated Muscle Contraction: Through Thick and Thin","volume":"86","year":"2024","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"key20260915123757_B44","article-title":"MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy","volume":"12","year":"2017","journal-title":"PLoS One"},{"issue":"476","key":"key20260915123757_B45","article-title":"Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin","volume":"11","year":"2019","journal-title":"Sci Transl Med"},{"issue":"6","key":"key20260915123757_B46","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1172\/JCI116101","article-title":"Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy","volume":"90","year":"1992","journal-title":"J Clin Invest"},{"issue":"1","key":"key20260915123757_B47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2009.11.062","article-title":"A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype","volume":"391","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"key20260915123757_B48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.10693","article-title":"Myosin storage myopathy associated with a heterozygous missense mutation in MYH7","volume":"54","year":"2003","journal-title":"Ann Neurol"},{"issue":"4","key":"key20260915123757_B49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1086\/424760","article-title":"Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1)","volume":"75","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"6","key":"key20260915123757_B50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/07853890.2014.912834","article-title":"A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy","volume":"46","year":"2014","journal-title":"Ann Med"},{"issue":"1","key":"key20260915123757_B51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1073\/pnas.0909468107","article-title":"Myosin ATP turnover rate is a mechanism involved in thermogenesis in resting skeletal muscle fibers","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"key20260915123757_B52","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.bpj.2011.02.061","article-title":"A new state of cardiac myosin with very slow ATP turnover: a potential cardioprotective mechanism in the heart","volume":"100","year":"2011","journal-title":"Biophys J"},{"key":"key20260915123757_B53","article-title":"To lie or not to lie: Super-relaxing with myosins","volume":"10","year":"2021","journal-title":"Elife"},{"issue":"10","key":"key20260915123757_B54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy","volume":"141","year":"2020","journal-title":"Circulation"},{"issue":"35","key":"key20260915123757_B55","first-page":"E8143","article-title":"Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers","volume":"115","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"key20260915123757_B56","article-title":"Molecular basis of force-pCa relation in MYL2 cardiomyopathy mice: Role of the super-relaxed state of myosin","volume":"119","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"key20260915123757_B57","article-title":"Single-molecule imaging reveals how mavacamten and PKA modulate ATP turnover in skeletal muscle myofibrils","volume":"155","year":"2023","journal-title":"J Gen Physiol"},{"issue":"10","key":"key20260915123757_B58","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20260915123757_B59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cvr\/cvu127","article-title":"Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations","volume":"103","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"21","key":"key20260915123757_B60","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","article-title":"Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy","volume":"144","year":"2021","journal-title":"Circulation"},{"issue":"6273","key":"key20260915123757_B61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","year":"2016","journal-title":"Science"},{"issue":"19","key":"key20260915123757_B62","doi-asserted-by":"crossref","first-page":"14142","DOI":"10.1021\/acs.jmedchem.1c01290","article-title":"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy","volume":"64","year":"2021","journal-title":"J Med Chem"},{"issue":"10253","key":"key20260915123757_B63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"key20260915123757_B64","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy","volume":"390","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"key20260915123757_B65","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa2505927","article-title":"Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy","volume":"393","year":"2025","journal-title":"N Engl J Med"},{"issue":"9 Pt B","key":"key20260915123757_B66","first-page":"1927","article-title":"Various Themes of Myosin Regulation","volume":"428","year":"2016","journal-title":"J Mol Biol"},{"issue":"2","key":"key20260915123757_B67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/bbrc.1999.1221","article-title":"Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene","volume":"262","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260915123757_B68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yjmcc.2008.05.003","article-title":"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C","volume":"45","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"key20260915123757_B69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10974-019-09513-1","article-title":"Troponin structure and function: a view of recent progress","volume":"41","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"issue":"10","key":"key20260915123757_B70","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1172\/JCI6460","article-title":"Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy","volume":"103","year":"1999","journal-title":"J Clin Invest"},{"issue":"9","key":"key20260915123757_B71","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1006\/jmcc.2000.1204","article-title":"Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy","volume":"32","year":"2000","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"key20260915123757_B72","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1006\/jmbi.1997.1145","article-title":"Tissue-specific expression and alpha-actinin binding properties of the Z-disc titin: implications for the nature of vertebrate Z-discs","volume":"270","year":"1997","journal-title":"J Mol Biol"},{"issue":"12","key":"key20260915123757_B73","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/humu.24470","article-title":"Mutation update for the ACTN2 gene","volume":"43","year":"2022","journal-title":"Hum Mutat"},{"issue":"11","key":"key20260915123757_B74","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jacc.2009.11.016","article-title":"Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis","volume":"55","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"key20260915123757_B75","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/hmg\/ddn160","article-title":"Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy","volume":"17","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"2","key":"key20260915123757_B76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.20892\/j.issn.2095-3941.2019.0420","article-title":"Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression","volume":"17","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"4","key":"key20260915123757_B77","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0735-1097(01)01509-1","article-title":"Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes","volume":"38","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20260915123757_B78","first-page":"123","article-title":"The FHL1 myopathy spectrum revisited: a literature review and report of two new patients","volume":"43","year":"2024","journal-title":"Acta Myol"},{"issue":"3","key":"key20260915123757_B79","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajhg.2009.07.015","article-title":"Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy","volume":"85","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"14","key":"key20260915123757_B80","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1093\/hmg\/dds157","article-title":"Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy","volume":"21","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"6","key":"key20260915123757_B81","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.RES.0000263008.66799.aa","article-title":"Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy","volume":"100","year":"2007","journal-title":"Circ Res"},{"issue":"4","key":"key20260915123757_B82","first-page":"1595","article-title":"Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines","volume":"98","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"key20260915123757_B83","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/CIRCULATIONAHA.107.711317","article-title":"Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy","volume":"116","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"key20260915123757_B84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvs294","article-title":"Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity","volume":"97","year":"2013","journal-title":"Cardiovasc Res"},{"key":"key20260915123757_B85","doi-asserted-by":"crossref","first-page":"RP104048","DOI":"10.7554\/eLife.104048.3","article-title":"Human formin FHOD3-mediated actin elongation is required for sarcomere integrity in cardiomyocytes","volume":"13","year":"2025","journal-title":"Elife"},{"issue":"1","key":"key20260915123757_B86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCGENETICS.112.965277","article-title":"Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy","volume":"6","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"key20260915123757_B87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s10038-018-0479-y","article-title":"Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy","volume":"63","year":"2018","journal-title":"J Hum Genet"},{"issue":"12","key":"key20260915123757_B88","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1253\/circj.CJ-13-0255","article-title":"Dilated cardiomyopathy-associated FHOD3 variant impairs the ability to induce activation of transcription factor serum response factor","volume":"77","year":"2013","journal-title":"Circ J"},{"issue":"2","key":"key20260915123757_B89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","year":"2021","journal-title":"Nat Genet"},{"issue":"2","key":"key20260915123757_B90","first-page":"530","article-title":"Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy","volume":"57","year":"2025","journal-title":"Nat Genet"},{"issue":"6","key":"key20260915123757_B91","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/humu.24004","article-title":"A mutation update for the FLNC gene in myopathies and cardiomyopathies","volume":"41","year":"2020","journal-title":"Hum Mutat"},{"issue":"22","key":"key20260915123757_B92","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"key20260915123757_B93","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1091\/mbc.e07-06-0628","article-title":"Identification of CAP as a costameric protein that interacts with filamin C","volume":"18","year":"2007","journal-title":"Mol Biol Cell"},{"issue":"12","key":"key20260915123757_B94","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1074\/jbc.R110.198697","article-title":"Signaling to myosin regulatory light chain in sarcomeres","volume":"286","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"key20260915123757_B95","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(01)00586-4","article-title":"The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation","volume":"107","year":"2001","journal-title":"Cell"},{"issue":"7","key":"key20260915123757_B96","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jmg.36.7.542","article-title":"Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy","volume":"36","year":"1999","journal-title":"J Med Genet"},{"issue":"10","key":"key20260915123757_B97","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling","volume":"42","year":"2005","journal-title":"J Med Genet"},{"issue":"10","key":"key20260915123757_B98","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.110.236067","article-title":"Strategic approaches to unraveling genetic causes of cardiovascular diseases","volume":"108","year":"2011","journal-title":"Circ Res"},{"issue":"14","key":"key20260915123757_B99","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"key20260915123757_B100","article-title":"Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity","volume":"8","year":"2021","journal-title":"Open Heart"},{"key":"key20260915123757_B101","doi-asserted-by":"crossref","first-page":"132213","DOI":"10.1016\/j.ijcard.2024.132213","article-title":"Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis","volume":"409","year":"2024","journal-title":"Int J Cardiol"},{"issue":"7319","key":"key20260915123757_B102","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Genomes Project C","year":"2010","journal-title":"Nature"},{"issue":"7920","key":"key20260915123757_B103","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04965-x","article-title":"The sequences of 150,119 genomes in the UK Biobank","volume":"607","year":"2022","journal-title":"Nature"},{"issue":"7063","key":"key20260915123757_B104","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nature04226","article-title":"A haplotype map of the human genome","volume":"437","year":"2005","journal-title":"Nature"},{"issue":"3","key":"key20260915123757_B105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/geno.1998.5466","article-title":"Cloning, characterization, and chromosomal localization of human superillin (SVIL)","volume":"52","year":"1998","journal-title":"Genomics"},{"issue":"23","key":"key20260915123757_B106","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1091\/mbc.e12-10-0714","article-title":"Supervillin binding to myosin II and synergism with anillin are required for cytokinesis","volume":"24","year":"2013","journal-title":"Mol Biol Cell"},{"key":"key20260915123757_B107","doi-asserted-by":"crossref","first-page":"132542","DOI":"10.1016\/j.ijcard.2024.132542","article-title":"The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy","volume":"417","year":"2024","journal-title":"Int J Cardiol"},{"issue":"19","key":"key20260915123757_B108","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2024.08.011","article-title":"Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up","volume":"84","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20260915123757_B109","doi-asserted-by":"crossref","first-page":"39357","DOI":"10.1038\/s41598-025-27238-9","article-title":"Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy","volume":"15","year":"2025","journal-title":"Sci Rep"},{"issue":"8081","key":"key20260915123757_B110","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41586-025-09272-9","article-title":"Whole-genome sequencing of 490,640 UK Biobank participants","volume":"645","year":"2025","journal-title":"Nature"},{"issue":"10","key":"key20260915123757_B111","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacbts.2020.05.013","article-title":"Clinical Interpretation and Management of Genetic Variants","volume":"5","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"key20260915123757_B112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HCO.0000000000001123","article-title":"Gene-based renaming of human diseases","volume":"39","year":"2024","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"key20260915123757_B113","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","year":"2023","journal-title":"Nat Med"},{"issue":"2","key":"key20260915123757_B114","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","year":"2023","journal-title":"Nat Med"},{"key":"key20260915123757_B115","article-title":"A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"key20260915123757_B116","article-title":"Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy","volume":"15","year":"2022","journal-title":"Circ Heart Fail"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:38:16Z","timestamp":1789475896000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1900\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["10.14797\/mdcvj.1900"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1900","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}